Cargando…
血小板计数检测在成人慢性原发免疫性血小板减少症利妥昔单抗疗效预测中的价值
OBJECTIVE: To investigate the value of platelet count in predicting the efficacy of rituximab treatment in chronic primary immune thrombocytopenia (ITP). METHODS: A retrospective study was conducted in 103 chronic ITP patients hospitalized in our medical center between January 2011 and December 2014...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342221/ https://www.ncbi.nlm.nih.gov/pubmed/30122017 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.07.009 |
Ejemplares similares
-
利妥昔单抗治疗特发性血栓性血小板减少性紫癜的临床研究
Publicado: (2015) -
利妥昔单抗治疗脾边缘区淋巴瘤致急性血小板减少一例报告并文献复习
Publicado: (2021) -
含利妥昔单抗联合方案治疗难治/复发血栓性血小板减少性紫癜10例临床分析
Publicado: (2018) -
艾曲泊帕治疗成人慢性原发免疫性血小板减少症的疗效及安全性
Publicado: (2018) -
大剂量地塞米松联合小剂量利妥昔单抗作为二线方案治疗65例原发免疫性血小板减少症患者的临床观察
Publicado: (2015)